Quarterly snapshots from biopharma companies with marketed products, including: Adamas, Astellas, Beigene, Dynavax, Exelixis, Fibrogen, Incyte, Morphosys, Novartis.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Boston Scientific, Life Spine, Magventure, United Imaging.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alume, Caligor, Blackrock Microsystems, Canon Medical Systems USA, Caris Life Sciences, Companion Medical, Curepsp, Dreamtech, Elevation Oncology, E7 Health, Epitomee Medical, Hemogenyx Pharmaceuticals, Hologic, Irras, Lianbio, Medcall, Medtronic, Mcfarlane Medical, Microgendx, Nestlé Health Science, Onlume, Painteq, Pccw Global, Perimeter Medical Imaging AI, Promega, Quidel, Sensifree, Sure Universal, Syapse, Titan Medical, Trendlines Group, Vonco Products, Wyss Center for Bio and Neuroengineering, Zebra Medical Vision.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Babylon, Beyond Air, Exthera, Neurologica.

Med-tech firms raising money in public or private financings, including: Bodyport, Lumeon.

New hires and promotions in the med-tech industry, including: Vida Diagnostics.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: American Gene Technologies, Arvelle, Atyr, Clearside, Equillium, Fennec, Kyorin, Mersana, Mesoblast, Neurogene, Protalix.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3Helix, Actinium, Altitude, Amydis, Ana, Appili, Arctic Vision, Aum, Axim, Beyond Air, Beyondspring, Biostem, Blue Tech, Bridgebio, Caris, Chrysalis, Elevation, Evotec, Eyenovia, Hemogenyx, Innate, Janone, Known Med, Lianbio, Ligand, Molecular Partners, Nascent, Nexeos, Quotient, Resolute, Revive, Saillant, Sapphire, Sarepta, Tevogen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Arcturus, Arrowhead, BMS, Byondis, Catalyst, Destiny, Eisai, Equillium, Fulcrum, Indalo, Kezar, Kymab, Revance, Romark, SAB, Tyme.

Biopharmas raising money in public or private financings, including: Akers, Atriva, Aveo, Betterlife, Citius, Diamedica, Genome, Harmony, Iterum, Northwest, Omeros, PDS, Santhera, Scioto, Tearclear, TFF.